Cost-effective chronic disease prevention in developing countries

发展中国家具有成本效益的慢性病预防

• 批准号: 8846002
• 负责人: Jeremy David Goldhaber-Fiebert
• 金额: $ 12.74万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8846002
• 关键词: Accounting; Address; Adult; Age; Asian Indian; Biological; Biology; Birth; Calibration; Calories; Cardiovascular Diseases; Cerebrovascular Disorders; Cessation of life; Child; Childhood; Chronic; Chronic Disease; Communicable Diseases; Communities; Computers; Consumption; Country; Developing Countries; Developmental Process; Diabetes Mellitus; Diabetes prevention; Diagnosis; Disease; Disease model; Econometric Models; Economics; Elderly; Environment; Epidemiology; Face; Food; Frail Elderly; Health; Health Benefit; Health system; Hospitalization; Household; Human Resources; Incidence; Income; India; Individual; Infection; Intervention; Knowledge; Life; Life Cycle Stages; Light; Link; Longitudinal Studies; Malnutrition; Mentors; Methods; Modeling; Non-Insulin-Dependent Diabetes Mellitus; Nutrition Policy; Nutritional; Nutritional status; Obesity; Obesity associated disease; Outcome; Pattern; Perception; Persons; Policies; Poverty; Prevalence; Prevention; Preventive Intervention; Price; Primary Prevention; Program Efficiency; Public Health; Reading; Regression Analysis; Research; Research Infrastructure; Research Training; Resources; Risk; Science; Secondary Prevention; Slum; Social Policies; Subgroup; Surveys; Taxes; Techniques; Time; Training; Tuberculosis; Underweight; Work; World Health Organization; base; combat; cost; cost effective; cost effectiveness; diabetic; disorder control; disorder prevention; early life exposure; economic impact; experience; health economics; high risk; improved; models and simulation; novel; novel strategies; programs; response; rural area; screening; skills; socioeconomics; transmission process

DESCRIPTION (provided by applicant): Despite the perception that infectious diseases and malnutrition are the main threats to health in the developing world, the reality is that the prevalence of chronic diseases is increasing rapidly. By 2030, chronic diseases are projected to cause more than 40% of deaths in developing countries, prompting a 2008 call from the World Health Organization to establish national action plans for their prevention and control. Such plans must overcome formidable resource constraints. Because chronic diseases overlap with persistent diseases of poverty, policy responses must contend with interacting risks from multiple diseases. For instance, the control of type 2 diabetes through social policies to reduce obesity must avoid exacerbating malnutrition, especially prevalent in children. Conversely, properly targeted diabetes prevention can also reduce tuberculosis prevalence. In countries like India, diabetes' biological link to increased risk of active tuberculosis infection accounts for an estimated 15% of overall tuberculosis incidence. It is, however, not obvious which groups to target as diabetes is more prevalent in middle income groups while tuberculosis is more common in the poor. Current policy assessment methods are insufficient for these problems, as typical analyses focus on the health benefits of addressing a single disease and, therefore, fail to account for important cross-disease effects. A novel approach is required that evaluates the life course benefits of each policy alternative based on its age- and subgroup-specific impact on multiple diseases. This K01 application outlines such an approach. Its training aims are to expand knowledge and skills in: (1) econometric and statistical techniques for analyzing large household surveys, longitudinal studies with non-random attrition, and social policies such as taxes that impact food prices, consumption, and nutritional health outcomes; (2) the life course, developmental processes leading to chronic diseases such as diabetes, cardiovascular and cerebrovascular diseases as well as the biology and epidemiology of persistent diseases of poverty like tuberculosis and malnutrition. This will be accomplished through relevant coursework, mentored directed reading, and seminar participation. This K01 develops specific examples whose logical extension to other countries and diseases indicates far-reaching applicability beyond the scope of the proposal and, hence, high public health significance. The methods developed, though broadly applicable, will be applied to the specific problem of diabetes in India. The specific research aims are: (1) develop a lifetime microsimulation model of type 2 diabetes to assess primary and secondary prevention interventions in Asian Indians; (2) evaluate the impact of nutrition policies on chronic diseases and malnutrition; (3) integrate tuberculosis transmission into the diabetes model to assess how rising diabetes prevalence alters tuberculosis prevalence via their biological interaction; (4) compare the benefits of prevention policies that target subpopulations with different diabetes and tuberculosis risk profiles. In order to determine model inputs, econometric regression and statistical calibration will be used.

描述（由申请人提供）：尽管人们认为传染病和营养不良是发展中国家健康的主要威胁，但现实情况是慢性病的患病率正在迅速增加。到2030年，慢性病预计将导致发展中国家40%以上的死亡，促使世界卫生组织在2008年呼吁建立预防和控制慢性病的国家行动计划。这些计划必须克服严重的资源限制。由于慢性病与持续性贫困疾病重叠，政策应对措施必须应对多种疾病相互作用的风险。例如，通过减少肥胖的社会政策控制2型糖尿病，必须避免加剧营养不良，特别是儿童中普遍存在的营养不良。相反，有针对性的糖尿病预防也可以降低结核病的患病率。在印度等国家，糖尿病与活动性结核病感染风险增加的生物学联系估计占结核病总发病率的15%。然而，针对哪些群体并不明显，因为糖尿病在中等收入群体中更为普遍，而结核病在穷人中更为常见。目前的政策评估方法不足以解决这些问题，因为典型的分析侧重于解决单一疾病的健康效益，因此未能考虑到重要的跨疾病影响。需要一种新的方法，根据每种政策对多种疾病的年龄和亚组特定影响，评估每种政策的生命周期效益。本K 01申请概述了这种方法。其培训目标是扩大以下方面的知识和技能：（1）分析大型家庭调查的计量经济学和统计技术，非随机损耗的纵向研究，以及影响食品价格、消费和营养健康结果的税收等社会政策;（2）生命过程、导致慢性疾病（如糖尿病）的发育过程，心脑血管疾病以及结核病和营养不良等持续性贫困疾病的生物学和流行病学。这将通过相关的课程，指导指导阅读，并参加研讨会来完成。K 01提出了具体的例子，其逻辑延伸到其他国家和疾病表明其具有超出提案范围的深远适用性，因此具有高度的公共卫生意义。开发的方法，虽然广泛适用，将适用于在印度的糖尿病的具体问题。具体的研究目标是：（1）开发2型糖尿病的终生微观模拟模型，以评估亚洲印第安人的初级和二级预防干预措施;（2）评估营养政策对慢性病和营养不良的影响;（3）将结核病传播纳入糖尿病模型，以评估糖尿病发病率的上升如何通过其生物相互作用改变结核病发病率;（4）比较针对具有不同糖尿病和结核病风险特征的亚群的预防政策的益处。为了确定模型输入，将使用计量经济回归和统计校准。

项目成果

Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997.

• DOI: 10.1186/1744-8603-7-45
• 发表时间: 2011-12-16
• 期刊: Globalization and health
• 影响因子: 10.8
• 作者: Chen BK;Seligman B;Farquhar JW;Goldhaber-Fiebert JD
• 通讯作者: Goldhaber-Fiebert JD

The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration.

按肝病阶段划分的丙型肝炎的费用：退伍军人健康管理局的估计。

• DOI: 10.1007/s40258-019-00468-5
• 发表时间: 2019
• 期刊: Applied health economics and health policy
• 影响因子: 3.6
• 作者: Gidwani-Marszowski,Risha;Owens,DouglasK;Lo,Jeanie;Goldhaber-Fiebert,JeremyD;Asch,StevenM;Barnett,PaulG
• 通讯作者: Barnett,PaulG

Optimal Information Collection Policies in a Markov Decision Process Framework.

马尔可夫决策过程框架中的最优信息收集策略。

• DOI: 10.1177/0272989x18793401
• 发表时间: 2018
• 期刊: Medical decision making : an international journal of the Society for Medical Decision Making
• 作者: Cipriano,LaurenE;Goldhaber-Fiebert,JeremyD;Liu,Shan;Weber,ThomasA
• 通讯作者: Weber,ThomasA

An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier.

一种识别成本效益边界的高效、非迭代方法。

• DOI: 10.1177/0272989x15583496
• 发表时间: 2016
• 期刊: Medical decision making : an international journal of the Society for Medical Decision Making
• 作者: Suen,Sze-chuan;Goldhaber-Fiebert,JeremyD
• 通讯作者: Goldhaber-Fiebert,JeremyD

Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.

• DOI: 10.1371/journal.pmed.1002532
• 发表时间: 2018-03
• 期刊: PLoS medicine
• 影响因子: 15.8
• 作者: Lin E;Chertow GM;Yan B;Malcolm E;Goldhaber-Fiebert JD
• 通讯作者: Goldhaber-Fiebert JD